Boit C.F. David’s AbbVie ABBV Stock Holding History

Boit C.F. David’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.19M	Hold	24,600	–	–	2.61%	11
2026 Q1	$5.35M	Hold	24,600	–	–	2.37%	13
2025 Q4	$5.41M	Hold	24,600	–	–	2.34%	15
2025 Q3	$5.7M	Hold	24,600	–	–	2.58%	14
2025 Q2	$4.57M	Hold	24,600	–	–	2.2%	18
2025 Q1	$5.15M	Hold	24,600	–	–	2.59%	13
2024 Q4	$4.37M	Hold	24,600	–	–	1.78%	17
2024 Q3	$4.84M	Hold	24,600	–	–	2.4%	14
2024 Q2	$4.22M	Hold	24,600	–	–	2.2%	16
2024 Q1	$3.98M	Hold	24,600	–	–	2.17%	16
2023 Q4	$3.95M	Hold	24,600	–	–	2.23%	15
2023 Q3	$3.65M	Hold	24,600	–	–	2.5%	13
2023 Q2	$3.31M	Hold	24,600	–	–	2.2%	17
2023 Q1	$3.97M	Hold	24,600	–	–	2.71%	12
2022 Q4	$3.98M	Hold	24,600	–	–	2.83%	10
2022 Q3	$3.3M	Buy	+24,600	New	+$3.53M	2.68%	12
2022 Q1	$4.1M	Hold	25,300	–	–	2.7%	13
2021 Q4	$3.43M	Hold	25,300	–	–	2.17%	18
2021 Q3	$2.76M	Hold	25,300	–	–	1.89%	17
2021 Q2	$2.85M	Buy	+25,300	New	+$2.85M	2.17%	17

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boit C.F. David's ABBV Position: Q2 2026 in Review

Boit C.F. David held its AbbVie (ABBV) position steady in Q2 2026 at 24,600 shares worth $6.19M. The position accounts for 2.61% of the portfolio, ranked #11.

Boit C.F. David first reported a position in ABBV in Q2 2021 and has held it in 20 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Boit C.F. David held 24,600 shares of AbbVie worth $6.19M as of Q2 2026.
Boit C.F. David left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 2.61% of Boit C.F. David's portfolio in Q2 2026, its #11 holding.
Boit C.F. David first reported a position in AbbVie in Q2 2021 and has held it in 20 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Boit C.F. David's 13F filing for Q2 2026, filed 30 Jul 2026.